Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations

Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nationsThe price tag is slightly below the range of $2,520 to $2,800 suggested last week by U.S. drug pricing research group the Institute for Clinical and Economic Review (ICER) after British researchers said they found that the cheap, widely available steroid dexamethasone significantly reduced mortality among severely ill COVID-19 patients. Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19. After the intravenously administered medicine helped shorten hospital recovery times in a clinical trial, it won emergency use authorization in the United States and full approval in Japan.




from https://news.yahoo.com/gilead-prices-covid-19-drug-111703954.html

Comments

Post a Comment

Popular posts from this blog

Steve Cohen is hyped for Mets-Braves: 'Doesn't get any better than this' - New York Post

Steve Cohen is hyped for Mets-Braves: 'Doesn't get any better than this'    New York Post Mets-Braves division showdown series FAQ    MLB.com Mets' comeback eases uncertainty of Atlanta series    Newsday 'This is what you play for': Braves know what's at stake in series versus Mets    The Atlanta Journal Constitution Braves' longtime mastery of Mets looms over enormous NL East series    New York Post
Read more

From India to China, the Taliban's return leaves Afghanistan’s neighbors scrambling to adjust - CNBC

From India to China, the Taliban's return leaves Afghanistan’s neighbors scrambling to adjust    CNBC China Sees Risks in Stepping Into Afghanistan After U.S. Withdrawal    The Wall Street Journal Pakistan's hand in the Taliban's victory    The Washington Post 'Shock and awe,' Taliban style | TheHill    The Hill Is China About to Tuck Afghanistan Under Its Belt and Road?    Bloomberg View Full Coverage on Google News
Read more